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Acute myocardial infarction (AMI) is a severe cardiovascular disease that is a serious
threat to human life. However, the specific diagnostic biomarkers have not been fully
clarified and candidate regulatory targets for AMI have not been identified. In order
to explore the potential diagnostic biomarkers and possible regulatory targets of AMI,
we used a network analysis-based approach to analyze microarray expression profiling
of peripheral blood in patients with AMI. The significant differentially-expressed genes
(DEGs) were screened by Limma and constructed a gene function regulatory network
(GO-Tree) to obtain the inherent affiliation of significant function terms. The pathway
action network was constructed, and the signal transfer relationship between pathway
terms was mined in order to investigate the impact of core pathway terms in AMI.
Subsequently, constructed the transcription regulatory network of DEGs. Weighted gene
co-expression network analysis (WGCNA) was employed to identify significantly altered
gene modules and hub genes in two groups. Subsequently, the transcription regulation
network of DEGs was constructed. We found that specific gene modules may provide a
better insight into the potential diagnostic biomarkers of AMI. Our findings revealed and
verified that NCF4, AQP9, NFIL3, DYSF, GZMA, TBX21, PRF1 and PTGDR genes by
RT-qPCR. TBX21 and PRF1 may be potential candidates for diagnostic biomarker and
possible regulatory targets in AMI.
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INTRODUCTION
Acute myocardial infarction (AMI) is a severe cardiovascular disease that is a serious threat to
human life (Roger et al., 2012). AMI can cause congestive heart failure and malignant arrhythmia
leading to a high morbidity and mortality (Jameel and Zhang, 2009; Mozaffarian et al., 2016).
While thrombolysis and percutaneous coronary intervention (PCI) can significantly improve the
prognosis of patients with AMI, there are still many patients with AMI that eventually develops
into heart failure or arrhythmia due to the unclear etiology of AMI (Eapen et al., 2012) Looking
for the potential diagnostic biomarkers and possible regulatory targets of AMI may help to
reduce the mortality of AMI. At present, the systems biology analysis of gene expression profiling
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provides a better method to elucidate the possible mechanisms
of myocardial infarction from the perspective of gene regulation.
Using gene expression profiles, we can obtain adequate
information about altered gene expression correlating with
disease. Kiliszek et al. (2012) utilized a microarray approach
to demonstrate that, during ST-segment elevation myocardial
infarction (STEMI), many genes have altered expression,
including those involved in various pathways related to
platelet function, lipid/glucose metabolism and atherosclerotic
plaque stability. Based on the system level of gene expression
profiling, gene co-expression network analyses could be an
alternative method for analyzing expression profiling data
(Stuart et al., 2003), in order to gain an insight into
molecular regulatory mechanisms of heart diseases caused
by myocardial infarction. Gene ontology (GO) and pathway
enrichment analyses were used in our study to explore the
molecular mechanisms of heart disease induced by myocardial
infarction.
Weighted gene co-expression network analysis (WGCNA)
was also used in this study, and is generally utilized for
illuminating the changes of transcriptome expression patterns
in complex diseases (Zhang and Horvath, 2005; Chen et al.,
2008; Voineagu et al., 2011). Compared with the standardized
analysis of DEGs, the purpose of which is to detect disease-
related individual genes, WGCNA aims to recognize higher-
order correlation between gene products (Oldham et al., 2008).
Moreover, the algorithm of WGCNA can substantially simplify
the multiple testing problems that are unavoidable in standard
gene-centric methods of microarray expression profiling data
analysis; therefore, it is a powerful systematic analysis method
that focuses on the coherence function of networkmodules (Zhao
et al., 2010).
Using the bioinformatics methods above, we analyzed GO-
tree, pathway action network and gene module alteration in
patients with AMI to explore the potential diagnostic biomarkers
and possible regulatory targets of AMI in our study. The
gene co-expression network was constructed based on the gene
expression profiling, and gene modules of peripheral blood were
also detected by theWGCNAwhen AMI occurred. Furthermore,
hub genes were recognized, which could be used as biomarkers
for assessing the severity of heart diseases and served as
promising therapeutic targets for promoting novel therapeutic
schedules in AMI. In summary, our study aimed to determine the
key genes that are involved in the regulation of AMI development
by bioinformatics analysis, which could be served as potential
targets for the diagnosis and treatment of AMI.
MATERIALS AND METHODS
Microarray Data and Analysis of
Differentially-Expressed Genes
The microarray expression data of peripheral blood samples
was obtained from GEO (http://www.ncbi.nlm.nih.gov/geo) and
GEO Series accession number GSE48060. This microarray
profiling was acquired from human peripheral blood samples of
31 AMI patients and 21 controls. 52 samples were profiled using
the chip-based platform GPL570 [HG-U133_Plus_2] Affymetrix
Human Genome U133 Plus 2.0 Array (Suresh et al., 2014).
The use of gene expression data from whole blood instead
of heart tissue samples may limit the ability of our approach
to detect signatures in the specific diseased tissue. However,
peripheral blood is more easily accessed than heart tissue and
may provide specific insights into the immune and inflammatory
response of AMI exacerbations.
Microarray data analysis was performed using R software and
Bioconductor 3.3 (http://www.bioconductor.org/). By quantile
normalization, base 2 logarithm conversions, background
correction and normalization were performed on original
expression data by Robust Multiarray Averaging (RMA) (Gautier
et al., 2004); as a result 54,675 mRNAs were carried over for
further analysis (Supplement Table 1).
We screened the significant DEGs from 31 AMI patients
and 21 controls by Limma (linear models for microarray data)
package of R 3.1.3 software (Sanges et al., 2007). The Fold change
> 1.2 and P < 0.05 was regarded as a threshold.
Cluster and TreeView are software programs for analyzing
and visualizing DNAmicroarray data or other genomic data sets.
In this study, Cluster analysis was used to differentially-expressed
genes data and then visualize the data through TreeView.
Gene Ontology (GO) and Pathway
Enrichment Analyses
GO analysis was utilized to explain the primary function of
the DEGs according to the GO database, which is the crucial
functional classification of NCBI (Ashburner et al., 2000; Gene
Ontology, 2006). Fisher’s exact test was used to calculate the
significance level (P-value) of each GO term to screen out the
significance GO term of the DEGs enrichment. While P < 0.05
was considered to be significant.
Analogously, pathway analysis was performed to discover the
significant pathway terms of the DEGs according to the Kyoto
Encyclopedia of Genes and Genomes (KEGG) (Kanehisa and
Goto, 2000). We used the Fisher’s exact test to identify the
significant pathway terms; a P < 0.05 was considered significant
(Kanehisa et al., 2004; Draghici et al., 2007).
Construction of Gene Function Regulatory
Network (GO-Tree)
The GO hierarchy was a directed acyclic graph (DAG), in which
each term had a defined link with one or more other terms. A
GO-Tree was constructed based on the GO DAG to supply clear
data navigation and visualization. P < 0.01 were selected for
statistical significance of GO terms in GO analysis, and the GO-
Tree was constructed using the up- and down-regulated DEGs in
order to outline the functions that influenced AMI (Zhang et al.,
2004).
Experimental genes also participated in many significant GO
analyses. We organized the mutual regulation and affiliations
between all GO analyses into the database based on a hierarchy of
GO. By building a functional relationship network, it was possible
to summarize the impact of the experimental function groups, as
well as internal affiliation significant features. We considered the
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biological process (BP) terms of GO analysis to build a network
of functional regulation (P < 0.01).
Construction of Pathway Action Network
(Pathway-Act-Network)
The KEGG database included signal transduction, metabolism,
cell cycle, membrane transport pathways and information of their
interactions. The genes we selected may be related to two or
more signaling pathways. Due to the same genes in different
pathways, overlapping between pathways was inevitable. We
selected the genes in enriched biological pathways and used
Cytoscape for graphical representations of pathways (Shannon
et al., 2003). By constructing the pathway action network, the
signal transfer relations between the pathways was explored at
a macro level. In order to look for the core pathways and
regulatory mechanisms affected by the disease from multiple
significant pathway terms, P < 0.05 of pathway terms in
pathway analysis were selected to construct a pathway action
network.
Co-expression Network Analysis
Gene co-expression network analyses (Kim et al., 2001) were
carried out to reveal the interrelation between the DEGs, based
on their normalized signal intensity in “AMI” and “Control”
profiles. The Pearson correlation was calculated for each pair
of genes, and the significantly correlated pairs were used to
construct the co-expression network (Prieto et al., 2008). To trace
the core regulatory genes in the networks, k-core scores were
applied to simplify the analysis of graph topology. The k-core
of a given gene indicated its core or nodal status linking other
genes in the network to “k” (Ravasz et al., 2002; Barabási and
Oltvai, 2004). Consequently, we applied k-core scores to identify
genes with the highest networking degrees as key regulatory
genes.
Weighted Gene Co-expression Network
Analysis
WGCNA is a common algorithm for constructing a co-
expression network. We utilized the similarity of gene co-
expression to define a network. When using Smn to represent
the gene co-expression similarity between genes m and
n, we can then apply the power adjacency function for
correlating adjacency of genes: Smn = |(1+ cor (xm, xn)) /2|
β.
In data processing, the genome-wide gene expression data was
preliminarily filtered, followed by measuring the consistency
of gene expression profiles by Pearson correlation, and finally
using the power adjacent function to Pearson correlation
matrix, data was transformed into weighted gene co-expression
networks.
Intramodular connectivity (IC) describes the correlation
degree of a gene with other genes in a given module, which
can be understood as a measure of module membership (MM).
Network module (Module) is a cluster of closely interconnected
genes. During module detection, the adjacency matrix (which
is a measure of topology similarity) is transformed into the
topological overlap matrix (TOM), and modules are detected
by cluster analysis (Zhao et al., 2014). We then analyzed
the importance of genes by the t-test to determine whether
the modules were associated with myocardial inflammation.
Module eigengene (ME) refers to the first principal component
gene of module expression matrix. It is considered the most
representative of the module genes, which has important
biological significance.
Functional Enrichment Analysis of the
Network Module Genes
The online tool PANTHER was used to analyze the functional
enrichment of network module genes that are associated with
myocardial inflammation (P < 0.05) (Mi et al., 2013).
Identification of Hub Genes
Hub genes are described as the genes most closely associated with
disease; they are connected to the highest degree of a series of
genes in a module. To a certain extent, they are used to determine
the character of modules, the hub genes of modules often have
more biological significance compared with the hub genes of
global networks (Jeong et al., 2001; Goh et al., 2007; Liang and
Li, 2007). A gene is considered to be a hub gene if it has a unique
character, such as high GS, high MM and high IC in the network
(Zhang and Horvath, 2005). Gene significance (GS) showed the
different IC of a gene in various networks, andMM described the
significance of genes in the network. The IC of a gene suggested
the connectivity with the other genes within network. We were
therefore also able to identify the hub genes in modules through
the GS, MM, and IC.
Transcription Regulatory Network
JASPAR (http://jaspar.genereg.net) is an open-access database
storing curated, non-redundant transcription factor (TF) binding
profiles representing transcription factor binding preferences as
position frequency matrices for multiple species in six taxonomic
groups (Mathelier et al., 2016). Cytoscape is a visualization data
integration package for biological networks based on the Java
language (Smoot et al., 2011). We imported DEGs into the
JASPAR database to obtain the interaction between transcription
factors and their target genes (TG). Then, we used Cytoscape
software to visualize these relationships and finally obtained the
transcription factor-target gene regulatory network.
Patients
The research object of this study with a total of 20, all are
hospitalized patients with AMI in the department of cardiology
of first hospital of Jilin university, and each was invited to join the
study patients are required to sign a consent form. Our research
protocol was approved by the ethical committee of the First
Hospital of Jilin University. Among the 20 patients, 12 males,
and 8 females, aged 57± 9 years. Inclusion criteria: chest pain or
distress within 24 h duration > 30min, and myocardial enzymes
CK-MB and cTNT higher than the normal range online. While
excluding myocarditis and other diseases caused by chest pain
or distress; exclude the patients with history of renal failure;
patients with advanced liver disease; patients with malignant
tumors and patients with other inflammatory diseases, such as
psoriasis, rheumatoid arthritis and so on.
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Quantitative Real-Time RT-qPCR
According to the microarray results, the 8 most dysregulated
mRNAs were chosen for further validation by RT-qPCR in AMI
patients vs. healthy controls. Blood samples were collected and
PBMCs were isolated. Total RNAs were isolated from PBMCs
using Trizol reagent (Invitrogen), and complementary DNA was
synthesized using the TransScript R©Frist-Strand cDNA Synthesis
SuperMix(Transgen, China)according to the manufacturer’s
instructions. Primer sets for selected genes were designed
by Sangon Biotech (Shanghai, China); their sequences and
reaction conditions are available in Table 1. Each sample was
run in triplicate in 96-well plates using LightCycler R©96 and
FastStart Essential DNA Green Master (Roche Diagnostics
GmbH, Germany). Quantification cycles (Cq) were calculated
using the fit pointmethod (LightCycler R©96 Software, Version 1.1
provided by Roche). The expression data were normalized to the
reference glyceraldehyde-3-phosphate dehydrogenase (Gapdh).
All experiments (sample collection, preparation and storage,
primer design, qPCR normalization) were performed according
to the MIQE guidelines.
TABLE 1 | PCR primers for quantitative real-time PCR.
Gene Primer sequence (5′−→3′)
GAPDH F : CCACATCGCTCAGACACCAT R : GGCAACAATATCCACTTTACCAGAGT
AQP9 F : GCCATCGGCCTCCTGATTAT R : GCCCACTACAGGAATCCACC
DYSF F : CCTGCCATGTTTCCCTCCAT R : AGGTAGGTGGTAGCCACGAT
GZMA F : CTGGAAGCCCTTTGTTGTGC R : CACGAGGGTCTCCGCATTTA
NCF4 F : TCCCAGATGAGCCACAATGC R : ATAGGGGAGTGCTGCTGAGA
NFIL3 F : CCGAGAACGTCGGAAACTGA R : TTGGCTTTGATCCGGAGCTT
PRF1 F : ACCTTCATCCAAGCATGGGG R : TATTGTCCCACACGGTGCTC
PTGDR F : CCTTCTTTGGGCTCTCCTCG R : GAACTTCCCGAAGCCCATGA
TBX21 F : CCACCTGTTGTGGTCCAAGT R : GGGAACATCCGCCGTCC
RESULTS
DEGs Selection and Hierarchical
Clustering Analysis
We used R software and corrected batch effect by Bayesian
methods, then removed the probes without corresponding
annotation information. To determine the expression values of
each gene, we used multiple GSE48060 probes corresponding to
the median expression value of that gene, and finally obtained the
expression profile of 54,675 genes (Supplement Table 1).
By using algorithms provided in the Limma package, we
calculated the data and obtained with lists of differentially
expressed genes. A total of 551 DEGs were identified between
the AMI group and the control group, including 164 upregulated
and 387 down-regulated genes (P < 0.05, Fold change > 1.2,
Figure 1A, Supplement Table 2). Hierarchical clustering analysis
was obtained for the 551 DEGs from the 52 samples of the AMI
and control groups. The general gene expression patterns were
evidently different in the two groups by TreeView (Figure 1B).
GO Enrichment Analysis of DEGs and
GO-Tree
To reveal AMI–related biological processes, we conducted a
functional enrichment analysis. GO enrichment analysis of 551
DEGs was performed. Themost GO terms of biological processes
were associated with inflammation, including the inflammatory
response, immune response, cellular defense response and
chronic inflammatory response in the AMI group (Figure 2A).
In the cellular component category, enriched GO terms were
mainly associated with lipid particles, the external side of the
plasma membrane and the extracellular space. In the molecular
function category, GO terms enriched for DEGs in AMI included
chemokine activity, GTP binding and carbohydrate binding
FIGURE 1 | DEGs selection and hierarchical clustering analysis. (A) The Limma algorithm was applied to filter the DEGs; we selected the DEGs according to
P < 0.05 and Fold change > 1.2. (B) DEGs can be effectively divided into AMI and control groups. Red indicates that the gene that is upregulated and green
represents down-regulated genes.
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FIGURE 2 | GO enrichment analysis and GO-Tree. (A) The significant GO terms that conformed to a P < 0.05 were screened. (B) GO-Tree: red circles represent
the upregulated genes involved in GO terms, and green circles represent the down-regulated genes involved in GO terms. (C) We used the Fisher’s exact test to
select the significant pathway, identified by a P < 0.05. (D) Pathway-act-network. P < 0.05. Red circles represent the upregulated genes involved in pathway terms,
and green circles represent the down-regulated genes involved in pathway terms.
(Table 2). We constructed gene function regulatory networks
(GO-Tree) for the significant GO terms (P < 0.01) of the
category of biological processes in GO analysis in order to explore
the intrinsic link among gene function (Figure 2B). We then
found the hierarchical tree relationships between gene function
significantly (Supplement Table 3). The analysis showed that the
gene function cascade eventually induced inflammation during
AMI.
Pathway Enrichment Analysis of DEGs and
Pathway-Act-Network Construction
To screen the significant enrichment of DEGs in pathway terms,
Fisher’s exact test was used to calculate the significance level
of the pathway (P < 0.05). According to KEGG databases, we
performed pathway annotation of DEGs and obtained DEGs
involved in all pathway terms (Figure 2C, Table 3). The DEGs of
AMI were enriched mainly in inflammatory bowel disease (IBD),
the chemokine signaling pathway, natural killer cell mediated
cytotoxicity, toll-like receptor signaling pathway and cytokine-
cytokine receptor interactions. As there was cross-talk between
the pathway terms, in order to search the transitive relation
between signaling pathways, we constructed pathway action
networks (pathway-act-network) for the significant pathway
terms (P < 0.05) (Figure 2D, Supplement Table 4). There were
interactions in multiple pathways, demonstrated by the pathway-
act-network, which ultimately impacted activation of multiple
pathway terms including the JAK-STAT signaling pathway, toll-
like receptor signaling pathways and antigen processing and
presentation.
Gene Co-expression Network
We performed a gene co-expression network analysis to
investigate the phenotypic change of genes associated with AMI
(Kumari et al., 2012; Villa-Vialaneix et al., 2013). Twelve genes
from the AMI and control groups were chosen as key regulatory
genes (
∣
∣Dif _Kcore
∣
∣ > 30), and it was shown that there was
a significant change in the expression pattern of genes in the
AMI group (Supplement Table 5), namely CNN2 (calponin
2), CRYZ (quinone oxidoreductase), SULT1A1 (sulfotransferase
1A1), SULT1A2 (sulfotransferase 1A2), PRMT2 (protein arginine
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TABLE 2 | Gene ontology (GO) enrichment analysis (top 5 significantly enriched biology terms).
ID Category Term Count p-value
BP (biological process) GO:0006954 Inflammatory response 25 3.72505E-06
GO:0008015 Blood circulation 9 4.228E-06
GO:0006935 Chemotaxis 15 2.2594E-05
GO:0006955 Immune response 27 2.44648E-05
GO:0006968 Cellular defense response 9 6.92717E-05
MF (molecular function) GO:0008009 Chemokine activity 8 9.08077E-05
GO:0005525 GTP binding 23 0.000533266
GO:0030246 Carbohydrate binding 13 0.000880498
GO:0000166 Nucleotide binding 79 0.001891473
GO:0003924 GTPase activity 15 0.002768396
CC (cellular component) GO:0005811 Lipid particle 6 0.004507736
GO:0009897 External side of plasma membrane 12 0.005867119
GO:0005901 Caveola 6 0.007176272
GO:0005615 Extracellular space 36 0.009088137
GO:0016324 Apical plasma membrane 13 0.010146435
TABLE 3 | KEGG enrichment analysis of genes (top 15 significantly enriched pathway terms).
ID Category Term Count p-value
KEGG_PATHWAY PATH:05321 Inflammatory bowel disease (IBD) 9 0.000234194
PATH:04062 Chemokine signaling pathway 15 0.000660309
PATH:05134 Legionellosis 7 0.001477228
PATH:05332 Graft-vs.-host disease 6 0.002078294
PATH:04650 Natural killer cell mediated cytotoxicity 11 0.002955348
PATH:04620 Toll-like receptor signaling pathway 9 0.004404204
PATH:05144 Malaria 6 0.004876618
PATH:04964 Proximal tubule bicarbonate reclamation 4 0.005750295
PATH:05330 Allograft rejection 5 0.006633034
PATH:04612 Antigen processing and presentation 7 0.009121472
PATH:04060 Cytokine-cytokine receptor interaction 15 0.011203809
PATH:04940 Type I diabetes mellitus 5 0.011308703
PATH:04970 Salivary secretion 7 0.016840879
PATH:05162 Measles 9 0.016897245
PATH:04976 Bile secretion 6 0.019514032
methyltransferase 2), ATP1B1 (ATPase, Na+/K+ transporting,
beta 1 polypeptide), CX3CR1 (CX3C chemokine receptor 1),
GCH1 (GTP cyclohydrolase 1), INSIG1 (insulin-induced gene
protein), CXCL5 (C-X-C motif chemokine 5), GBP3 (guanylate-
binding protein 3) and HEG1 (heart development protein with
EGF-like domains 1).We hypothesized that the 12 key regulatory
genes are likely to be closely related to the occurrence and
development of AMI (Figure 3).
However, traditional studies of gene co-expression patterns
mainly utilize the Pearson coefficient to describe the correlation
between genes, and tend to determine the presence of a co-
expression network using the Pearson coefficient and FDR
threshold (also known as hard threshold) (Butte and Kohane,
2000; Carter et al., 2004; Prieto et al., 2008). The two genes are
considered to be connected when the correlation coefficient of
two genes is equal to or greater than this threshold (for example,
0.8). However, there is a significant limitation to this method,
i.e., we have no evidence to identify whether the coefficient 0.8
or 0.79 of two genes has a significant difference. The above
algorithm cannot avoid this situation. WGCNA is different
from the traditional gene-gene correlation coefficient matrix, and
introduces a soft-threshold method that avoids this limitation.
In WGCNA, the correlation coefficient in genes of a gene co-
expressionmatrix is obtained by weight calculation. The standard
of weighting is the connections between genes, which should
conform to the distribution of scale-free networks, obeying a
power-law distribution. In short, the correlation coefficient of
each gene pair was the β-th power of the exponent operation,
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FIGURE 3 | Gene co-expression network analyses. The Pearson correlation was calculated for each pair of genes, and the significantly correlated pairs were
used to construct the co-expression network (P < 0.05). (A) AMI. (B) Control. Red nodes represent the key regulatory genes with the highest K-Core. The node color
represents the K-Core. The node size represents the K-Core power, and the edges between two nodes represent the interactions between the genes.
which was the weight calculation and β was known as the soft
threshold.
Weighted Gene Co-expression Networks
We selected a suitable weighted parameter of adjacency function,
which is the soft-threshold β, before constructing the weighted
co-expression network. After the calculation, we selected the
correlation coefficient close to 0.8, soft-threshold β = 9 to
construct gene modules using the WGCNA package.
After determining the soft threshold, a total of 551 DEGs
were used to construct weighted gene co-expression networks.
According to the basic idea of WGCNA, we calculated the
correlation matrix and adjacency matrix of the gene expression
profile of the AMI and control groups, and then transformed
them into a topological overlap matrix (TOM), and obtained a
system clustering tree of DEGs on the basis of gene-gene non-
similarity (dωij =1− ωij). Together with the TOM, we performed
the hierarchical average linkage clustering method to identify the
gene modules of each gene network (deep split = 2, cut height
= 0.99). In both the AMI and control groups, a total of five gene
modules were recognized by the dynamic tree cut (Figure 4A).
Genes that not belong to any modules were housed in the gray
module. The gray gene modules were ignored in this study.
GO Enrichment Analysis of the Gene
Modules
For a preliminarily test to assess whether the network was
acceptable, we derived the corresponding genes of each module,
and PANTHER was used for the functional enrichment analysis
of GO terms, P < 0.05 (Mi et al., 2013). For the blue module,
genes involved in the inflammatory response (GO: 0006954,
P = 1.81E-07), immune response (GO: 0006955, P = 1.54E-
05), defense response (GO: 0006952, P = 5.12E-05) and immune
system process (GO: 0002376, P = 1.35E-03) were significantly
enhanced (Table 4). It is suggested that this module is closely
related to the occurrence and development of the immune and
inflammation responses in AMI. Meanwhile, by analyzing the
brown module, it is evident that the module gene is mainly
concentrated in the immune response (GO: 0006955, P =
8.83E-06), regulation of lymphocyte chemotaxis (GO: 1901623,
P = 1.05E-05), defense response (GO: 0006952, P = 2.03E-
05), response to stimulus (GO: 0050896, P = 9.99E-05) and
immune system process (GO: 0002376, P = 1.53E-04) (Table 4).
These results indicate that the module may be closely related to
the immune response during AMI. The gene modules that we
obtained have biological significance, so we named the blue and
brown modules as immune modules. The functional enrichment
analysis of blue and brown modules indicates that the immune
response and inflammation would immediately follow the onset
of AMI, which is consistent with previous reports (Fang et al.,
2015).
A major goal of our research was to analyze the degree
of correlation between genes and disease, and to ascertain
the significance of genes in the corresponding modules. We
defined GS as the association of a gene with immune and
inflammatory responses. Then we calculated the mean GS of
all genes in the module, which is module significance (MS),
and described subsequently the relationship between modules
and the inflammatory response (Langfelder and Horvath, 2008).
Figure 4B showed the correlation between the various modules
and immune/inflammatory responses, which shows that themost
relevant modules to the immune and inflammatory responses
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FIGURE 4 | (A) Network analysis of gene expression in AMI identifies distinct modules of co-expression genes. (B) Correlation between the gene modules and
immune and inflammatory responses. Scatter plot of MM vs. GS in (C) blue and (D) brown modules. Cor represents an absolute correlation coefficient of GS and MM;
P-value for significance assessment. It follows that in both modules, GS and MM have a high correlation. In the high correlation of image: upper right node (gene) and
immune and inflammatory responses, on the other hand in the module also has an important significance.
were the blue and brown modules. For a particular gene, to
evaluate its involvement in the given module, we analyzed the
correlation between its expression profile and ME profile in
all samples. We calculated the MM of all the genes in the
corresponding module to learn their significance within the
given modules. We identified modules (blue and brown) that
showed a high correlation with immune and inflammatory
reactions, and GS and MM of each gene are shown in
Figures 4C,D.
Hub Genes Associated with the
Occurrence of AMI
The above results suggested that the occurrence and development
of AMI were closely related to the immune and inflammatory
responses. To screen genes that were most relevant to
immune and inflammatory responses, we constructed the gene
co-expression network of immune module genes. There was a
positive correlation between MM and IC in the modules, but not
GS. Therefore, we selected the hub genes according to the IC
and MM values of each gene module (Table 5). Eight hub genes
were selected, including NCF4, AQP9, NFIL3, DYSF, GZMA,
TBX21, PRF1, and PTGDR. Combined with previous reports,
we hypothesized that these hub genes were closely relevant to
immune and inflammatory responses when AMI occurs. The co-
expression network of module genes was then constructed to
obtain the degree of connection between genes in the module
(Figures 5A,B).
Transcription Regulatory Network
Based on JASPAR database, the transcription regulatory
network of DEGs was constructed and included 66 nodes
(Figure 6A). There were 30 transcription factors, and the
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TABLE 4 | Gene ontology (GO) enrichment analysis in gene modules (top 8 significantly enriched biology terms).
Module ID Category Term Count p-value
Blue BP (biological process) GO:0006954 Inflammatory response 19 1.81E-07
GO:0006955 Immune response 30 1.54E-05
GO:0006952 Defense response 30 5.12E-05
GO:0002376 Immune system process 34 1.35E-03
GO:0050896 Response to stimulus 74 4.54E-03
GO:0042742 Defense response to bacterium 10 5.12E-03
GO:0006950 Response to stress 44 2.17E-02
GO:0098542 Defense response to other organism 12 2.58E-02
Brown BP (biological process) GO:0006955 Immune response 45 1.22E-11
GO:0006952 Defense response 45 8.05E-11
GO:0002376 Immune system process 51 8.13E-09
GO:0006954 Inflammatory response 23 1.02E-08
GO:0050896 Response to stimulus 105 7.10E-08
GO:0006950 Response to stress 64 1.77E-06
GO:0009605 Response to external stimulus 45 4.41E-06
GO:0033993 Response to lipid 26 6.67E-06
FIGURE 5 | Construction of a co-expression network of module genes. (A) Blue module; (B) brown module. Red nodes represent the hub genes with the
highest K-Core and MM. The node color represents the K-Core. The node size represents the K-Core power, and the edges between two nodes represent the
interactions between the genes.
core transcription factors were SATA4, BCL11B, GATA3,
and TBX21, which have the regulatory relationship with the
most target genes. (TG > 10, Supplement Table 6). Combined
with the results of WGCNA analysis, we found that the
transcription factor TBX21 was a hub gene. We screened all
target genes associated with the transcription factor TBX21
and constructed a transcriptional regulatory network centered
around TBX21 (Figure 6B). Significantly, TBX21 was directly
related to the transcription factors SATA4, BCL11B, and
GATA3.Interestingly, these four transcription factors were
also directly related to PRF1, and PRF1 was also a hub
gene.
Validation of Microarrays with RT-qPCR
RT-qPCR was used to validate the microarray data. To verify
the main conclusion drawn from the microarray results for
peripheral blood samples, the expression levels of genes coding
for NCF4, AQP9, NFIL3, DYSF, GZMA, TBX21, PRF1, and
PTGDR were determined. Overall, the RT-qPCR results were
qualitatively consistent with the results of the microarray
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TABLE 5 | The hub genes in the brown and blue module (MM > 0.9).
Module Gene
symbol
Description Log2FC P-value FDR Style Intramodular
connectivity
MM module K-core
Brown NKG7 Protein NKG7 −0.59977622 4.57E-04 0.081114 Down 12.92371 0.9597275 6
Brown GZMA Granzyme A −0.5650966 6.70E-04 0.089693 Down 12.57077 0.9525589 6
Brown TBX21 T-box 21 variant −0.548076 7.24E-05 0.035039 Down 11.24149 0.9409293 6
Brown PRF1 Perforin-1 −0.56140565 1.81E-05 0.017504 Down 10.67641 0.934967 6
Brown KLRD1 Natural killer cells antigen CD94 −0.76968129 4.09E-05 0.027231 Down 10.22693 0.9252181 6
Brown PTGDR Prostaglandin D2 receptor −0.59329129 2.47E-05 0.021076 Down 9.142072 0.916501 6
Blue NCF4 Neutrophil cytosol factor 4 0.451293433 0.0043104 0.177619 Up 33.50208 0.9637546 14
Blue DYSF cDNA FLJ55344, highly similar to
Dysferlin
0.460010493 0.0010058 0.103739 Up 32.4434 0.9613569 14
Blue GLT1D1 cDNA FLJ51476 0.44564518 0.0011065 0.105197 Up 31.61535 0.9595483 14
Blue AQP9 cDNA FLJ50860, highly similar to
Aquaporin-9
0.531897672 0.0042735 0.176717 Up 32.72345 0.9488406 14
Blue PYGL Alpha-1,4 glucan phosphorylase 0.399190191 0.0187515 0.272497 Up 30.81584 0.9454835 14
Blue DGAT2 Diacylglycerol O-acyltransferase 2 0.422619622 0.0032528 0.163039 Up 29.01008 0.9349146 14
Blue BASP1 Brain acid soluble protein 1 0.475512299 0.0103385 0.226315 Up 30.82379 0.9330127 14
Blue GCA cDNA FLJ52146, highly similar to
Grancalcin
0.281390861 0.0423062 0.332922 Up 30.09932 0.9316431 14
Blue NFIL3 Nuclear factor, interleukin 3
regulated, isoform CRA_a
0.477300573 0.0130679 0.244778 Up 28.80993 0.9294694 14
Blue ACSL1 cDNA FLJ76467, highly similar to
Homo sapiens acyl-CoA
synthetase long-chain family
member 1 (ACSL1), mRNA
0.518836972 0.0125705 0.242483 Up 30.37111 0.9289425 14
Blue SULT1B1 Sulfotransferase family cytosolic
1B member 1
0.519448931 4.21E-04 0.077407 Up 26.96646 0.9233878 14
Blue KLHL2 Kelch-like protein 2 0.343649623 0.0317126 0.30949 Up 26.99282 0.9210025 14
Blue MGAM Maltase-glucoamylase
(Alpha-glucosidase), isoform
CRA_a
0.507642227 0.0313529 0.308545 Up 28.52488 0.9204113 14
Blue SLC2A3 cDNA FLJ57557, highly similar to
Solute carrier family 2, facilitated
glucose transporter member 3
0.274927717 0.0484124 0.347472 Up 24.5968 0.9038037 14
analysis. However, the RT-qPCR analysis tended to give higher
up-regulation levels than those calculated from the microarray
data. The highest change was found for TBX21, PRF1, andNFIL3
(Figure 7).
DISCUSSION
Although the appropriate thromboprophylaxis treatments
for AMI have reduced successfully the incidence and
mortality of AMI to some extent (Lau and Lip, 2014),
effective methods for preventing and diagnosing AMI are
still controversial. In our study, we use a systematic biology
approach to identify 551 DEGs in blood samples from AMI
patients compared with control groups. For enrichment
analysis of pathways, DEGs were mainly involved in IBD,
the chemokine signaling pathway, toll-like receptor signaling
pathway and cytokine-cytokine receptor interactions. From
the functional enrichment and GO-Tree analysis, we found
that the major biological processes are the inflammatory
response, chemotaxis, the immune response and the cellular
defense response when AMI occurs; these are functional
annotations associated with the immune and inflammatory
responses.
In the WGCNA, we identified five gene modules based
on 551 DEGs. Each module contained 44–279 genes;
only 36 genes failed to be assigned to any of the gene
modules. By functional enrichment analysis, the modules
have obvious biological significance, the genes of blue and
brown modules were significantly enriched in immunity
and inflammation-related biological processes. The majority
of genes within the turquoise module were involved in
mRNA processing and transcription, and the yellow module
genes were involved mainly in platelet coagulation and
activation.
Through the enrichment function analysis of the module
genes, we determine that accompanied by the activation of
inflammatory response signal pathways and the initiation of
immune system when AMI occurs. After the analysis of
WGCNA, we selected the blue and brown modules, which
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FIGURE 6 | Transcription regulatory network of DEGs. Based on JASPAR database, the transcription regulatory network constructed by DEGs included 66
nodes (A). (B) Construction of transcription regulatory network centered around TBX21. Red V-type represents up-regulated TF, green V-type represents
down-regulated TF; red circles represent up-regulated TG, green circles represent the down-regulated TG.
FIGURE 7 | Validation of microarray data with RT-qPCR. Several hub
genes identified in microarray data are dysregulation in AMI patients. mRNA
expression of hub genes identified in microarray data validated by RT-qPCR is
shown. Total RNAs were isolated from PBMCs or AMI patients and healthy
donors. Reverse-transcribed to cDNA and used as template for RT-qPCR
analysis. Relative Expression of each gene in PBMCs from healthy donors
were considered as 1.
were closely related to inflammatory reaction, as the main
research objects. Eight potential hub genes related to AMI
were screened from blue and brown modules, namely NCF4,
AQP9, NFIL3, DYSF, GZMA, TBX21, PRF1, and PTGDR.
Subsequently, RT-qPCR was used to verify the expression of
the eight hub genes in peripheral blood of AMI patients.
Our results suggested that the expression was consistent
with the bioinformatics analysis results. Wherein the most
obvious change of hub genes was TBX21 and PRF1, which
expression were significantly down-regulated in peripheral
blood of AMI patients. In combination with the results of
transcriptional regulatory network analysis, we hypothesized
that transcription factor TBX21 and target gene PRF1 may
be the diagnostic biomarkers of AMI and merit further
explored.
Gene TBX21 can encode a transcription factor named T-
bet, whose main function is to suppress GATA-3 expression
and prevent Th1 to Th2 cell differentiation (Szabo et al.,
2000). It is well known that patients with AMI can develop
subsequently cardiac arrest (Vanbrabant et al., 2006). Upon
cardiac arrest, an abnormal stress response occurs and causes
the change of transcription factor T-bet/GATA-3, resulting in
the imbalance of Th1/Th2. The Th2-type cytokine-induced
waterfall-like cascade is then initiated, which results in multiple
organ failure, eventually leading to death. This has also
been confirmed by a porcine model of cardiac arrest that
lowers GATA-3 and T-bet levels, which alters the drifting
Th1/Th2 cells and causes the immune imbalance of myocardial
tissue after cardiopulmonary resuscitation (CPR) (Gu et al.,
2013).
Perforin (PRF1) can be secreted by NK cells, CTL cells, γδ+T
and regulatory T cells. PRF1 is a protein in the membrane
attack complex/PR (FMACPF) superfamily (Lichtenheld et al.,
1988; Shinkai et al., 1988), which is a highly conserved
glycoprotein. Due to its important functions in immune
surveillance and immune regulation, the malfunction of
PRF1 has been found to be involved in many diseases
(Baran et al., 2009). Thiery and Lieberman showed that
PRF1 can activate clathrin- and dynein-dependent endocytosis,
and inhibition of this endocytosis pathway may trigger
apoptotic cell death (Thiery and Lieberman, 2014). In a
study of 495 patients with cardiomyopathy, the infiltration of
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perforin-positive cells in the myocardium could serve as a
predictor for long-term prognosis of patients; the presence of
perforin-positive infiltration in myocardial cells indicates an
adverse left ventricular ejection fraction (LVEF) course (Escher
et al., 2014). We speculate that the abnormal expression of
perforin may be a major cause of progressing LV dysfunction
in AMI.
There is no report about the relationship between the TBX21
and PRF1 by far. It may be the focus of follow-up work that the
potential regulatory role of TBX21 on PRF1 or other target genes
in AMI. The highlight of this study was to identify several hub
genes associated with AMI through the network analysis and to
validate the expression levels of these hub genes by RT-qPCR
experiments, including TBX21 and PRF1. We hypothesized that
TBX21 and PRF1may be potential candidates for diagnostic and
possible regulatory targets in the diagnosis and treatment of AMI.
Our results provide us a direction for subsequent research in
exploring thoroughly the gene regulatory mechanisms of AMI
and its targeted therapy.
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